A phase I/II dose escalation study of Apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia
- Thomas S. Lin
- , Wendy Stock
- , Huiping Xu
- , Mitch A. Phelps
- , Margaret S. Lucas
- , Sara K. Guster
- , Bruce R. Briggs
- , Carolyn Cheney
- , Pierluigi Porcu
- , Ian W. Flinn
- , Michael R. Grever
- , James T. Dalton
- , John C. Byrd
Producción científica: Article › revisión exhaustiva
33
Citas
(Scopus)